Law360, New York (December 27, 2010, 11:22 AM EST) -- Attorneys flagged the American Needle decision limiting joint ventures as the most significant antitrust ruling of 2010, but the year mostly saw big wins for big business, including rulings supporting drugmakers' pay-for-delay deals and a victory for companies facing consumer demands for post-merger divestitures.
Elsewhere, the patent misuse doctrine earned the spotlight this year, with the U.S. Court of Appeals for the Federal Circuit limiting its scope and drawing a thicker line between patent and antitrust law.
Here's a roundup of the most influential rulings of...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.